Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Xeris Biopharma Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get XERS alertsSteven M. Pieper is recorded as CFO at Xeris Biopharma Holdings, Inc. (XERS). The newest filing on record that lists Steven M. Pieper as CFO at Xeris Biopharma Holdings, Inc. (XERS) is dated April 23, 2026. The proxy statement of Xeris Biopharma Holdings, Inc. reports total compensation of $1,874,090 for Steven M. Pieper in fiscal 2025, including a base salary of $505,393. Disclosed compensation is on record for 3 fiscal years. Xeris Biopharma Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Xeris Biopharma Holdings, Inc. includes John P. Shannon (CEO and Board Member), John Shannon (CEO, Chairman, COO and Board Member), Marla S. Persky (Chairman) and 7 others.
Start not stated–present
Last confirmed April 23, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Financial Officer | $505,393 | $1,874,090 |
| 2024 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Financial Officer | $479,583 | $1,854,017 |
| 2023 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Financial Officer | $435,985 | $1,611,142 |
No call appearances or filed executive changes recorded yet.